Stocks-SAN.PA-Sanofi

SAN.PA Sanofi

89.20 -0.65 (-0.72%)
Priser fra Xignite, i EUR Markedet er åpent
Investere
-2.02% Forrige uke
Created with Highcharts 4.2.7 /Highstock 4.2.7
Markedsverdi
111.92B
Dagens område
88.92
-
89.87
52U-område
76.38
-
106.54
Volum (3M)
1.78M
Pris-inntjeningsforhold
16.93
Inntekt
40.22B
Festet innlegg
Redigert
Smart Portfolios Community
@etoro-portfolios talk about @diabetes-med game changer 🩺 👉 Diabetes is a significant health challenge that is expected to affect a growing number of people in the coming years. There are two main types of diabetes, Type 1 and Type 2, and treatment varies depending on the type. 👉 Type 1 diabetes... Vis flere Oversett
Lik KommenterDel
1 svar
null
.
Diskusjoner om Topp
Guillaume Fromentin
•••More than 424 million boxes: Sanofi has never produced as much Doliprane in France as in 2022 •••More than 424 million Doliprane boxes were produced and delivered to France by Sanofi in 2022, the company said. •••This is a record production since the beginning of the marketing of this drug in 1964. •••A... Vis flere Oversett
European Economies Stocks
Dear Investors, Here is your monthly update for December 2022. ✨ Most financial markets stuck to the trend for 2022, ending the year with losses. China on the other hand managed to buck this trend after the Chinese government's decision to relax their zero-covid policies. 💭 Find out more about... Vis flere Oversett
Kévin Didier Roger
📰 Actualités 📰 Le groupe pharmaceutique $SAN.PA (Sanofi) a annoncé jeudi que la Food and Drug Administration, l'autorité sanitaire américaine, avait accepté d'examiner la demande de licence pour le nirsevimab, un vaccin pour la prévention du virus respiratoire syncytial chez les nourrissons. Oversett
Edoardo Merenda
$SAN.PA (Sanofi) DEPAKIN CHRONO 300 is out of stock in many pharmacies. It is used in the treatment of manic episodes related to bipolar disorder when lithium is contraindicated or not tolerated. There are no alternatives with other medicines Oversett
SAN.PA
Sanofi
89.20
-0.65 (-0.72%)
Handle
Laith Al Ansari
I closed this trade at a gain of 15.78% on 06/01/2023 $FRA40 $GER40 $EUSTX50 $SAN.PA (Sanofi) $UK100 $AUS200 Oversett
Laith Al Ansari
@laithamin1984 lukket en $SAN.PA kjøpe-posisjon
Jordan
SAN.PA
Sanofi
15.78%
Handelshistorikk

Om Sanofi

Sanofi er et fransk farmasøytisk selskap, som driver med produksjon og distribusjon av legemidler og terapier. Selskapet opererer over hele verden. Sanofi ble grunnlagt i 1973, og har hovedkontor i Paris i Frankrike. Sanofi er notert i EUR på Euronext Paris, hvor de har aksjesymbolet SAN.PA. Lær mer om SAN.PA-aksjen på eToro.
95.4K
Ansatte
EU
Hovedkontor
1994
Grunnlagt
Paul Hudson
CEO
Show More

Kommende inntekter

3
FEB
RAPPORTER
Sanofi Q4 2022 det forventes at inntektsrapporten publiseres etter at markedet åpner

ESG: En ny kilde til innsikt

Få innsikt i et selskaps bærekraft ved hjelp av ESG-score (environmental, social, and governance).
0
100
48
Lav
Bransje 
Gj.sn. 47 
72
Miljø
62
SOSIALT
25
Styring

Folk kjøpte også